The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states

Union Information and Broadcasting Minister Prakash Javadekar said those who go to government centres will be administered the vaccine free of cost

The duration of Kumbh Mela, which is considered as the largest religious gathering anywhere around the world, has been reduced to just 30 days in view of the COVID-19 pandemic

The office order issued by Registrar General Manoj Jain said, \"The Full Court has been pleased to order that the existing system of hearing the matters in this court shall continue up to March 12, 2021

Speaking at an AIMA event here, Guleria said the vaccine is the only weapon available to gain immunity and help reduce mortality rate due to the infectious disease

PM Modi calls for lower import dependence as petrol prices touch Rs 100; COVID-19 vaccine likely to be available in open market after 'prime targets' covered, says Randeep Guleria, AIIMS Director; South African variant could significantly reduce vaccine protection, says Pfizer. Watch this and more news on News Blast.

South African variant could significantly reduce vaccine protection, says Pfizer A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer-BioNTech vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday. Companies are making investments and talking to regulators about developing an updated version of their mRNA vaccine or a booster shot, if needed. COV...

Saying that vaccination is necessary to fight the pandemic, Guleria urged people to not be afraid of the vaccine as it is totally safe.

For admission in these new streams, students won't have to go through the Joint Entrance Exam (JEE) system which has been the regular admission process for decades

According to experts, people have adopted a \"wait and watch\" approach which has resulted in low turnout at vaccination centres

Global economic outlook remains highly uncertain: IMF chief The head of the International Monetary Fund said on Monday the global economic outlook remained highly uncertain given the coronavirus pandemic, and a growing divergence between rich and poor countries required the IMF to find more resources. IMF Managing Director Kristalina Georgieva said a new allocation of the IMF's own currency, Special Drawing Rights, would help give countries more fiscal space to tackle the health crisis and ...

People adopting a \"wait and watch\" approach, lack of communication and glitches in CoWin app are the major reasons why only 53 per cent people got the COVID-19 shots on the first day in Delhi, experts said on Sunday

Sputnik V vaccine phase 3: The Data and Safety Monitoring Board (DSMB) had reviewed the safety data from phase 2 trials of the vaccine and stated that there were no safety concerns attached to the jab earlier this week

COVID-19 vaccination drive India: Dr Guleria was the third person to take the shot. Before him, a sanitation worker and a healthcare worker got vaccinated

Around 3 lakh frontline healthcare workers will be inoculated at 2,934 sites across the country on the first day of January 16, according to Health Ministry

Dr Randeep Guleria, Director, AIIMS, in an interview with India Today TV talks about the plan for vaccination in India. Healthcare and frontline workers, the aged and people with comorbidities would be given priority. Dr Guleria explains.Also Read: 10% COVID-19 vaccines will be wasted, says Centre; to cost Rs 1,320 crore more

Defending Covaxin, the Bhart Biotech Chairman said that his company has tremendous experience in developing vaccines; more than 70 articles on data related to Covaxin have been published in various journals

The ICMR head emphasised that the scientists at ICMR have been successfully able to culture the UK strain and the efficacy of Covaxin against it will be further tested in days to come

Calling it a great day for the country, AIIMS Director Dr Randeep Guleria said that initially Serum-AstraZeneca's Covishield will be administered to the people

AIIMS Director Dr Randeep Guleria said the COVID-19 virus has undergone several mutations - an average of two per month - without leading to any changes in symptoms or treatment